FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37179956> ?p ?o ?g. }

• Q37179956 description "article científic" @default.
• Q37179956 description "article scientifique" @default.
• Q37179956 description "articolo scientifico" @default.
• Q37179956 description "artigo científico" @default.
• Q37179956 description "artículu científicu espublizáu en 2013" @default.
• Q37179956 description "bilimsel makale" @default.
• Q37179956 description "scientific article published on 31 January 2013" @default.
• Q37179956 description "vedecký článok" @default.
• Q37179956 description "vetenskaplig artikel" @default.
• Q37179956 description "videnskabelig artikel" @default.
• Q37179956 description "vědecký článek" @default.
• Q37179956 description "wetenschappelijk artikel" @default.
• Q37179956 description "wissenschaftlicher Artikel" @default.
• Q37179956 description "наукова стаття, опублікована в січні 2013" @default.
• Q37179956 description "научни чланак" @default.
• Q37179956 description "مقالة علمية نشرت في 31 يناير 2013" @default.
• Q37179956 name "Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial" @default.
• Q37179956 name "Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial" @default.
• Q37179956 name "Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial" @default.
• Q37179956 type Item @default.
• Q37179956 label "Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial" @default.
• Q37179956 label "Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial" @default.
• Q37179956 label "Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial" @default.
• Q37179956 prefLabel "Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial" @default.
• Q37179956 prefLabel "Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial" @default.
• Q37179956 prefLabel "Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial" @default.
• Q37179956 P1433 Q37179956-E0E44012-3BE9-4780-8E2C-4EED35D84F2B @default.
• Q37179956 P1476 Q37179956-A8FD2D99-CCB7-40A2-8BE3-0DBA423A8018 @default.
• Q37179956 P2093 Q37179956-077FE099-39AE-4656-8B24-B3E150E09C4A @default.
• Q37179956 P2093 Q37179956-24C01FEE-72A8-4FCF-87FE-DDE64F352038 @default.
• Q37179956 P2093 Q37179956-2769F00C-AAE8-4F4F-8CE8-80C5CDD893C4 @default.
• Q37179956 P2093 Q37179956-2F99617D-27BD-4C4F-B072-C7D1E12E3184 @default.
• Q37179956 P2093 Q37179956-400212E7-C993-4302-A26D-532A1C167A7B @default.
• Q37179956 P2093 Q37179956-44B1D752-49B8-4D67-A4FE-279DDE569720 @default.
• Q37179956 P2093 Q37179956-5A155CC0-6240-48B5-B84E-542A3C1D2854 @default.
• Q37179956 P2093 Q37179956-6E65A046-14A5-4CC8-A789-825EBCAB4AA4 @default.
• Q37179956 P2093 Q37179956-906E9E43-BF56-4B8C-BCFA-2CE69DA8CBAE @default.
• Q37179956 P2093 Q37179956-A547E55D-65A8-476C-9B1B-B323B5A16C96 @default.
• Q37179956 P2093 Q37179956-BCFF0505-E645-4299-9DFC-34286527889C @default.
• Q37179956 P2093 Q37179956-C939390A-BFBE-420C-A258-E701DB223AB4 @default.
• Q37179956 P2093 Q37179956-FB7816A0-AFA6-4FF0-B106-9E79AB9D6A31 @default.
• Q37179956 P2860 Q37179956-01700FEE-F125-494F-8A1A-F11CB4ABD669 @default.
• Q37179956 P2860 Q37179956-1823031C-511F-45A9-8BCA-3103ED5952B9 @default.
• Q37179956 P2860 Q37179956-2178C931-E8A1-4A59-94DD-400A507E7FE8 @default.
• Q37179956 P2860 Q37179956-2869D6EA-13FA-4A0F-855B-444B598D8720 @default.
• Q37179956 P2860 Q37179956-2BD55664-3AE5-4A82-8D96-4077A820475D @default.
• Q37179956 P2860 Q37179956-2F5C0461-D234-4AA1-9AF8-D1B5BE0AFFBE @default.
• Q37179956 P2860 Q37179956-3C58DE81-3F53-41B1-B11E-B7FBC9DC329D @default.
• Q37179956 P2860 Q37179956-5838177B-BFA5-4624-9836-94962B37B92F @default.
• Q37179956 P2860 Q37179956-5EB34051-0C7A-463D-9DDA-9F51BAEED7CD @default.
• Q37179956 P2860 Q37179956-6725FD08-9878-484E-A187-D4CC7C5F75D0 @default.
• Q37179956 P2860 Q37179956-68DCB2AC-211C-405A-A26C-D45CDF5C3864 @default.
• Q37179956 P2860 Q37179956-6F4DEC95-ECAE-4DDA-9102-E1896CB3CB56 @default.
• Q37179956 P2860 Q37179956-83172ABF-DA37-4685-96D5-AE69CFB059DD @default.
• Q37179956 P2860 Q37179956-835E2286-2D00-448E-A81F-678A34BDB315 @default.
• Q37179956 P2860 Q37179956-96299ACB-F368-455F-85C5-98AC68A3B0E1 @default.
• Q37179956 P2860 Q37179956-981BF666-74E4-421B-A857-663C87B2F436 @default.
• Q37179956 P2860 Q37179956-A40B74B6-5EF1-49EA-B9A3-39B55B44E6F2 @default.
• Q37179956 P2860 Q37179956-A66A865F-FD5A-4F58-945C-76848469FA89 @default.
• Q37179956 P2860 Q37179956-A96A9B30-FAC0-44BD-B329-A72F3868D01D @default.
• Q37179956 P2860 Q37179956-BF514DCA-441A-4CCD-BA24-E705295A4C78 @default.
• Q37179956 P2860 Q37179956-D2FF369C-A984-408A-B45A-5C1CF7BDB909 @default.
• Q37179956 P2860 Q37179956-DA70F1A1-D6FF-473C-A675-7CC8D61CC6DF @default.
• Q37179956 P2860 Q37179956-DFE83655-B726-46AA-AF23-6910688490A3 @default.
• Q37179956 P2860 Q37179956-E09FA220-D8DD-429B-BE7D-59DFAF993A4D @default.
• Q37179956 P2860 Q37179956-E6D88B76-E9B1-482D-B3C2-C3FC54035772 @default.
• Q37179956 P2860 Q37179956-F706C70A-33F7-4D81-A6F7-E46F01A5EBAB @default.
• Q37179956 P304 Q37179956-C5005711-3742-4986-9F94-3413D839D378 @default.
• Q37179956 P31 Q37179956-8C3364FC-213D-4971-A8A7-472E452E6BEF @default.
• Q37179956 P356 Q37179956-4120E78C-E956-4ACC-BCA0-FB3E1681DC5A @default.
• Q37179956 P433 Q37179956-F0EEA0FA-4B1A-49F3-BAFE-64A38067DAF3 @default.
• Q37179956 P478 Q37179956-D689E035-4F22-4133-8D90-C57B88A2BB0C @default.
• Q37179956 P50 Q37179956-0FEA81D4-CFD4-4B4B-AA1D-8E443E5B1F24 @default.
• Q37179956 P50 Q37179956-1575D9E0-523B-4051-900F-C51D357159B6 @default.
• Q37179956 P50 Q37179956-1600F408-FBBC-4900-80F6-93E5CC9BD59D @default.
• Q37179956 P50 Q37179956-197D3778-2439-4000-96D1-8006BB5D3688 @default.
• Q37179956 P50 Q37179956-2576A3B6-66DE-4926-B6F6-3F297CFF0B8B @default.
• Q37179956 P50 Q37179956-2CB32AD4-B468-4187-883D-9F8C21CDB630 @default.
• Q37179956 P50 Q37179956-92907FA5-E630-419D-8F77-7512FA10F4B0 @default.
• Q37179956 P50 Q37179956-A0A25329-1B3D-4C41-8FDC-7E293C1920B9 @default.
• Q37179956 P50 Q37179956-A93FEFF4-988D-483B-9A8B-FB0D30A01FE5 @default.
• Q37179956 P50 Q37179956-B2379C5A-B19E-46F5-B040-94202770C9E2 @default.
• Q37179956 P577 Q37179956-45E39F3E-8501-4E0F-AA30-B0F14BDBB80A @default.
• Q37179956 P5875 Q37179956-124CCB83-C652-4B2D-B8E7-324A0838B220 @default.
• Q37179956 P698 Q37179956-B3927963-B583-45D7-B77E-7B1FBB671C71 @default.
• Q37179956 P921 Q37179956-2919BDAA-D6FA-4D42-B65B-B3CF7746F7BE @default.
• Q37179956 P921 Q37179956-5ED8AD43-97EC-45CA-8EA4-1B76EA0AD7F8 @default.
• Q37179956 P921 Q37179956-A94AE461-4517-4C43-ACEF-817C8A84E367 @default.
• Q37179956 P932 Q37179956-4178561B-B775-4BA7-9877-ACC56EF39C84 @default.
• Q37179956 P356 S1474-4422(13)70014-0 @default.
• Q37179956 P698 23375965 @default.
• Q37179956 P1433 Q15755067 @default.
• Q37179956 P1476 "Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial" @default.
• Q37179956 P2093 "Isaac Melamed" @default.
• Q37179956 P2093 "James Stevens" @default.
• Q37179956 P2093 "Jan-Philipp Bach" @default.
• Q37179956 P2093 "Jens Wiltfang" @default.
• Q37179956 P2093 "Jerome Goldstein" @default.
• Q37179956 P2093 "Judith Alferink" @default.
• Q37179956 P2093 "Markus Otto" @default.

• next